The FDA’s approval of the first therapy to treat Alzheimer’s Disease in over twenty years brought attention to a not-yet-convened debate of U.S. health care costs and spending, innovation, and return-on-the-investment (as well as “for whom” do the returns accrue). In my latest post for Medecision, I explore different angles on the Aduhelm and Alzheimer’s… Read More »
Researchers at La Jolla Institute for Immunology (LJI) have found that T cells from people who have recovered from COVID-19 or received the Moderna or Pfizer-BioNTech vaccines are still able to recognize several concerning SARS-CoV-2 variants. Their new study, published online on July 1, 2021 in Cell Reports Medicine, shows that both CD4+ “helper” T… Read More »
Dive Brief: U.S. News & World Report’s annual best hospitals rankings will include a number of new categories and other tweaks when the 2021-2022 list comes out July 27, according to a statement released Wednesday. The publication is ranking hospitals on seven new procedures and conditions, including heart attack, stroke, pneumonia, diabetes, kidney failure, hip… Read More »